Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 4 Lymphoma 2 Thymoma 1 Neuroendocrine Tumors 1 Lymphoma, Non-Hodgkin 1 Leukemia 1 Histiocytosis, Sinus 1 Hematologic Neoplasms 1 Erdheim-Chester Disease 1

Interventions

Radiotherapy 5 Cisplatin 5 pembrolizumab 4 Cyclophosphamide 4 Thymectomy 3 Sunitinib 3 130-nm albumin-bound paclitaxel 3 selinexor 2 Pemetrexed 2 Methylprednisolone 2 Etoposide 2 Drug Therapy 2 Doxorubicin 2 Chemoradiotherapy 2 Carboplatin 2 zimberelimab 1 vorolanib 1 regorafenib 1 lenvatinib 1 epacadostat 1 envafolimab 1 bosutinib 1 amrubicin 1 Thoracic Surgery, Video-Assisted 1 TP protocol 1 Ramucirumab 1 Radiotherapy, Adjuvant 1 Radiosurgery 1 Radiofrequency Ablation 1 Radiation Dose Hypofractionation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Thymoma × 68Ga-pentixafor × Clear all

NCT06086327 2023-10-17

Application of 68Ga-Pentixafor PET/CT for Thymoma

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Unknown

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡